Daily non-political popular news in brief.

Exclusion of common bile duct stones prior to gallstone operations

In the era of laparoscopic surgery, intra-operative X-ray investigation of bile ducts to identify coexisting common bile duct stones has been replaced by new techniques, which, unfortunately, are either too expensive and not available to all patients, or invasive and may result in severe complications. A study recently reported in the Nov. 21 issue of the World Journal of Gastroenterology may offer a simple and available measure to solve this problem worldwide.

Read more »

Keywords: exclusion, bile, duct, stones, prior, gallstone, operations, stone, operation

« Previous | Next »

Similar news on "Exclusion of common bile duct stones prior to gallstone operations":

1. M-POSSUM, an effective risk assessment system prior to operation
   10-09-2007 · EurekAlert!
   With progress in the medical sciences, operative indications are being expanded, the range of possible operations is growing and operative complications are increasing accordingly. The assessment of the functional condition of organs and systems helps in the quantifying of operative risks. Assessment methods allow us to judge the state of an illness and carry out the appropriate preventive treatment immediately, thereby decreasing operative complications and mortality. M-POSSUM is such a tool.
   Similar news · Read more »
   
2. The most important candidate genes for pancreatic stone formation
   11-13-2007 · EurekAlert!
   Chronic pancreatitis, an inflammatory condition of the pancreas, is usually associated with parenchymal calcification and multiple stones in the pancreatic duct. Lithostathine, a major proteic component of pancreatic stones, is thought to play an important role in stone formation. A research group from India has investigated if mutations in the gene encoding lithostathine (reg1) are responsible for stone formation, using tropical calcific pancreatitis as their model of chronic pancreatitis.
   Similar news · Read more »
   
3. 'Dua Anti-reflux Valve' found to improve quality of life for bile duct/pancreatic cancer patients
   12-11-2006 · EurekAlert!
   An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee. The study, using the anti-reflux biliary stent in patients with cancer of the pancreas or bile duct, has been accepted for publication in the journal Gastrointestinal Endoscopy.
   Similar news · Read more »
   
4. Hypnosis reduces pain and costs in breast cancer surgery
   08-28-2007 · EurekAlert!
   The use of hypnosis prior to breast cancer surgery reduced the amount of anesthesia administered during the operation, the level of pain reported afterwards, and the time and cost of the procedure, according to a study published online Aug. 28 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
5. Dua anti-reflux stent relieves GI upper cancer distress
   04-25-2007 · EurekAlert!
   An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee. The study, using the anti-reflux biliary stent in patients with cancer of the pancreas or bile duct, appears in the May issue of Gastrointestinal Endoscopy journal.
   Similar news · Read more »
   
6. Correlation between bile duct obstruction and ductal cancer found
   04-29-2007 · EurekAlert!
   When bile duct cancer cells were placed in the liver of animals with bile duct obstruction, they grew more rapidly than identical cells placed in animals without bile duct obstruction. In fact, half of the total liver mass of the rats with bile duct obstruction became replaced by cancer cells within three weeks compared to only 16 percent of that of animals without bile duct obstruction.
   Similar news · Read more »
   
7. Dua anti-reflux stent relieves GI upper cancer distress
   04-27-2007 · EurekAlert!
   An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee. The study, using the anti-reflux biliary stent in patients with cancer of the pancreas or bile duct, appears in the May issue of Gastrointestinal Endoscopy journal.
   Similar news · Read more »
   
8. OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer
   10-28-2007 · EurekAlert!
   Oregon Health & Science University researchers are reporting the discovery of an early survival advantage when a combination of surgery and radiation therapy is used for patients with a rare but deadly bile duct cancer. "Surgery and radiotherapy shows an early response benefit. It shows that the addition of radiation is potentially reasonable for the first-line treatment," said Clifton David Fuller, M.D., Ph.D., principal investigator of the study.
   Similar news · Read more »
   
9. Endosonography-guided biliary drainage is useful in cases with failed endoscopic biliary stenting
   11-02-2007 · EurekAlert!
   Endosonography-guided biliary drainage is a new method that enables internal drainage of bile. A research group led by Professor Naotaka Fujita in Japan performed histological examination of and around the fistula created by ESBD in a patient with ampullary carcinoma. No hematoma, bile leakage, or abscess was observed at the site of puncture in the duodenum and bile duct wall and in/around the sinus tract. These findings may encourage more active use of ESBD in cases with failed endoscopic biliary stenting.
   Similar news · Read more »
   
10. Study looks at off-label use of biliary stents
    01-21-2008 · EurekAlert!
    Although approved by the US Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used "off-label" for the treatment of peripheral vascular disease. A study in today's issue of the American Journal of Therapeutics finds that off-label use of biliary stents is increasing, and that the majority of adverse events and device malfunctions associated with the use of these stents occurs during off-label usage.
    Similar news · Read more »